Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 schedule
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedAbout Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 schedule
Abbreviated Zagreb 2-1-1 schedule + Standard Essen 1-1-1-1-1 schedule is a phase 3 stage product being developed by Novartis for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT00825305. Target conditions include Rabies.
What happened to similar drugs?
2 of 14 similar drugs in Rabies were approved
Approved (2) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00825305 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies